Multiple Myeloma
Multiple myeloma (MM) is a cancer of the plasma cells, a type of white blood cell that helps fight infection. It is the second most common blood cancer and accounts for about 1% of all cancers. MM is a serious disease, but thanks to advances in treatment, the outlook for patients has improved significantly in recent years.
There are several treatment options available for MM, including chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplant. The goal of treatment is to kill cancer cells, reduce symptoms, and prolong survival. Some people with MM may be able to achieve long-term remission or even a cure. However, due to some cancer cells developing resistance to treatment, it can come back even after successful treatment.
Researchers are also developing new treatments for MM, such as gene therapy and personalized medicine. These treatments are designed to target cancer cells more specifically and reduce side effects. Ongoing clinical trials are continually showing promising results and working towards improving the outcome and quality of life for patients with MM.
Few of the trials for this disease are listed below.

© 2023-24 DxMultiomics. All rights reserved.